Humble adventures of an inquisitive spirit ...

 A broad roadmap and challenges of going from LLMs to AGI to ASI.  A raw transcript of exploring the ideas with Mixtral. [DS]: What are implications of possessing the AGI capability by a for profit organisation? [Mixtral-8x7b-32768]: The development and deployment of AGI by a for-profit organization has significant implications for society, the economy, and the future of work. Here are some potential implications to consider: 1. Concentration of power: A for-profit organization that possesses AGI capability may have significant power and influence over markets, industries, and even governments. This could lead to concerns about concentration of power and the potential for abuse. 2. Economic disruption: AGI has the potential to automate many jobs and industries, leading to significant economic disruption and potential job losses. While AGI may also create new opportunities and industries, the transition could be challenging and may exacerbate economic inequality. 3. Ethical consideratio

Can humans live long and healthy lives? How long is "long"? I've been following Dr. David Sinclair, a renowned researcher in the field of aging and longevity. Here are the important for me points of his message, in context of increasing the longevity and health span in humans: 1. Targeting Aging as a Disease: Dr. Sinclair emphasizes the importance of targeting aging as a disease rather than treating individual age-related diseases separately. He argues that addressing the underlying biological processes of aging can have a more significant impact on overall health and longevity. 2. NAD+ and Sirtuins: Dr. Sinclair highlights the role of NAD+ (nicotinamide adenine dinucleotide) and sirtuins (a family of proteins) in the regulation of cellular health and aging. He explains that increasing NAD+ levels and activating sirtuins can improve cellular health and delay aging. 3. Metformin and Rapamycin: Dr. Sinclair discusses the potential of drugs like metformin and rapamycin in in

This filing has a potential to be a case of the century Musk vs Altman & Co A complaint filed by Elon Musk and several other plaintiffs against OpenAI, LLC, and its CEO, Sam Altman. The key points of the document are as follows: 1. The plaintiffs allege that OpenAI, a company founded in 2015, was initially established as a "capped" or "member-limited" artificial intelligence (AI) research company, meaning that it was not allowed to generate profits for its members or shareholders. 2. OpenAI later restructured as a for-profit corporation, OpenAI, LP, in 2019, with OpenAI, LLC, serving as its general partner. The plaintiffs argue that this restructuring violated the original intent of OpenAI's founding and the expectations of its members. 3. The plaintiffs claim that OpenAI, LP, is now primarily focused on generating profits for its members and shareholders, rather than prioritizing the broader societal benefits of AI research. 4. The plaintiffs argue that Op